Rankings
▼
Calendar
IRWD Q3 2016 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$600M
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$66M
Gross Profit
$29M
43.2% margin
Operating Income
-$28M
-42.8% margin
Net Income
-$33M
-50.2% margin
EPS (Diluted)
$-0.23
QoQ Revenue Growth
+21.6%
Cash Flow
Operating Cash Flow
-$645,000
Free Cash Flow
-$2M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$732M
Total Liabilities
$673M
Stockholders' Equity
$59M
Cash & Equivalents
$183M
← FY 2016
All Quarters
Q4 2016 →
